Literature DB >> 21860361

The effect of patient load on antiretroviral treatment programmatic outcomes at primary health care facilities in South Africa: a multicohort study.

Geoffrey Fatti, Ashraf Grimwood, Eula Mothibi, Jawaya Shea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21860361     DOI： 10.1097/QAI.0b013e318229baab

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  12 in total

1.  Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.

Authors:  Margaret L McNairy; Matthew R Lamb; Elaine J Abrams; Batya Elul; Ruben Sahabo; Mark P Hawken; Antonio Mussa; Ayele Zwede; Jessica Justman; Wafaa M El-Sadr
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

2.  Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.

Authors:  Margaret L McNairy; Matthew R Lamb; Rosalind J Carter; Ruby Fayorsey; Gilbert Tene; Vincent Mutabazi; Eduarda Gusmao; Millembe Panya; Mushin Sheriff; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

3.  Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study.

Authors:  Morna Cornell; Richard Lessells; Matthew P Fox; Daniela B Garone; Janet Giddy; Lukas Fenner; Landon Myer; Andrew Boulle
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

4.  High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.

Authors:  Justen Manasa; Richard J Lessells; Andrew Skingsley; Kevindra K Naidu; Marie-Louise Newell; Nuala McGrath; Tulio de Oliveira
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

5.  A South African public-private partnership HIV treatment model: viability and success factors.

Authors:  Jude Igumbor; Sophie Pascoe; Shuabe Rajap; Wendy Townsend; John Sargent; Ernest Darkoh
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

Authors:  Peter Bock; Geoffrey Fatti; Nathan Ford; Karen Jennings; James Kruger; Colette Gunst; Françoise Louis; Nelis Grobbelaar; Kwame Shanaube; Sian Floyd; Ashraf Grimwood; Richard Hayes; Helen Ayles; Sarah Fidler; Nulda Beyers
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

7.  Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.

Authors:  Morna Cornell; Leigh F Johnson; Robin Wood; Frank Tanser; Matthew P Fox; Hans Prozesky; Michael Schomaker; Matthias Egger; Mary-Ann Davies; Andrew Boulle
Journal:  J Int AIDS Soc       Date:  2017-09-25       Impact factor: 5.396

8.  The effects of decentralising antiretroviral therapy care delivery on health outcomes for adolescents and young adults in low- and middle-income countries: a systematic review.

Authors:  Roxanna Haghighat; Janina Steinert; Lucie Cluver
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

9.  Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.

Authors:  Portia C Mutevedzi; Richard J Lessells; Marie-Louise Newell
Journal:  Trop Med Int Health       Date:  2013-06-03       Impact factor: 2.622

10.  Retention in care and factors critical for effectively implementing antiretroviral adherence clubs in a rural district in South Africa.

Authors:  Peter Bock; Colette Gunst; Leonard Maschilla; Rory Holtman; Nelis Grobbelaar; Dillon Wademan; Rory Dunbar; Geoffrey Fatti; James Kruger; Nathan Ford; Graeme Hoddinott; Sue-Ann Meehan
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.